Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Document › Details

Genfit S.A.. (9/26/16). "Press Release: H1 2016 Results. Cash Position at End of Period at €94m and Significatn Advances in Elafibranor Program". Lille & Cambridge, MA.

Organisations Organisation Genfit S.A. (Nasdaq + Euronext: GNFT – ISIN: FR0004163111)
  Group Genfit (Group)
  Organisation 2 University of Antwerp
Products Product elafibranor (GFT505)
  Product 2 clinical research
Persons Person Mouney, Jean-François (Genfit 201909– Board Chairman before 1999–201909 CEO + Co-Founder)
  Person 2 Arabian, Bruno (Ulysse Communication 201807 before Milestones 201511)
     


   
Record changed: 2016-10-08

Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Genfit (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top